Serial SBRT Potentially Beneficial in Oligometastatic Prostate Cancer - Renal and Urology News

-

Serial stereotactic body radiation therapy (SBRT) directed by positron emission tomography (PET) using novel radiotracers may offer clinical benefits in patients with oligometastatic prostate cancer, according to a recent retrospective study.

The study's findings suggest that a second course of SBRT for men with recurrent oligometastatic prostate cancer following an initial course of SBRT is an important therapeutic strategy to consider, Daniel H. Kwon, MD, of the University of California, San Francisco, and colleagues reported in Urologic Oncology.

The study included 25 men with 1-5 prostate cancer metastases detected on PSMA (prostate-specific membrane antigen) or fluciclovine PET and who underwent 2 consecutive courses of SBRT. At the time of the second SBRT course, PSMA and fluciclovine PET detected oligorecurrent disease in 17 (68%) and 8 (32%) patients, respectively. Of the 25 patients, 15 (60%) had castration-sensitive disease and 10 (40%) had castration-resistant disease.

Continue Reading

Following the second SBRT course, 16 patients (64%) achieved a 50% or greater decline in PSA level (PSA50), Dr Kwon's team reported. The median progression-free survival (PFS) time was 11 months. The median survival time without initiation or intensification of androgen deprivation therapy (ADT) was 23.2 months. From the first SBRT course to the last follow-up (a median of 48 months), 7 patients (28%) remained ADT-free, Dr Kwon's team reported.

A PSA50 response after the first SBRT course was significantly associated with a 64% decreased risk for disease progression and a 93% decreased risk for ADT initiation or intensification after the second SBRT course.

"Degree of biochemical response to first SBRT warrants further study as a potential predictor of PSA response, PFS, and ADT initiation/intensification-free survival following a subsequent SBRT course," they concluded.

After controlling for potential confounders, the degree of biochemical response after the first SBRT course and concurrent change in systemic therapy with the second SBRT course were significantly associated with a greater likelihood of a PSA50 response and longer PFS after the second SBRT course, according to the investigators.

"Our study adds to the limited but growing literature supporting the feasibility and potential clinical benefit of serial metastasis-directed SBRT guided by novel radiotracers and PET imaging," the authors wrote.

The authors wrote that their preliminary findings provide a rationale for larger and prospective studies of serial SBRT.

Reference

Kwon DH, Shakhnazaryan N, Shui D, et al. Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers. Urol Oncol. Published online November 24, 2022. doi:10.1016/j.urolonc.2022.10.025

Topics:

Imaging Prostate Cancer Radiotherapy

Comments

Post a Comment

Popular posts from this blog

I Wish I Didn't Need an Oncologist at All, But I'm Thankful for the One ...

-
Image
efudex side effects :: Article Creator Inmates Given Ivermectin In Jail Will Each Get $2,000 After Settlement Your browser is not supporteddetroitnews.Com detroitnews.Com wants to ensure the best experience for all of our readers, so we built our site to take advantage of the latest technology, making it faster and easier to use. Unfortunately, your browser is not supported. Please download one of these browsers for the best experience on detroitnews.Com Efudex Cream Efudex Cream Generic Name & Formulations General Description Fluorouracil 5%. Pharmacological Class Antimetabolite. How Supplied Soln (w. Drop dispenser)—10mL, 25mL; Crm—40g Efudex Cream Indications Indications Multiple actinic or solar keratoses. Superficial basal cell carcinoma when conventional therapy is impractical (5% only); see full labeling. Efudex Cream Dosage and Administration Adult Keratoses: Apply twice daily until eros
Read more

Early symptoms of cancer in males: Common warning signs

-
Image
fluciclovine f 18 :: Article Creator The U.S. Navy Might Be Done With The F/A-18 Super Hornet Fighter Will The U.S. Navy Receive Its Final F/A-18 Super Hornets? - Around the holidays, money can be tight, a fact that the United States Navy has also learned as its negotiations to buy the last batch of Super Hornets are reportedly stalled over the growing price tag. USNI News reported on Tuesday that the contract for the U.S. Navy to purchase the final twenty F/A-18 E/F Super Hornets from aerospace giant Boeing appears to be at a standstill. The Navy continues to work with Boeing on the contract for the 20 congressionally added Super Hornet aircraft. Ongoing contract negotiations cannot be discussed at this time," Capt. Michael Burks, the program manager for the F/A-18 and EA-18G office at Naval Air Systems Command, told USNI News in a statement. Previous estimates put the unit cost of the final batch of aircraft at $55.7 million, and la
Read more

20 Famous Men Who Have Had Prostate Cancer

-
Image
leukemia treatment options :: Article Creator Current And Breakthrough Treatments For Chronic Lymphocytic Leukemia (CLL) Chronic lymphocytic leukemia (CLL) is a slow-growing cancer of the immune system. Because it's slow-growing, many people with CLL won't need to start treatment for many years after their diagnosis. Once the cancer begins to grow, there are many available treatment options that can help people achieve remission. This means people can experience long periods of time when there's no sign of cancer in their bodies. The exact treatment option that you'll receive depends on a variety of factors. This includes: whether your CLL is symptomatic the stage of the CLL, based on results of blood tests and a physical exam your age your overall health While there's no cure for CLL yet, breakthroughs in the field are on the horizon. Doctors typically stage CLL using a system called the Rai system. Low
Read more